The Ornithine Transcarbamylase (OTC) Deficiency Treatment market is witnessing significant transformation driven by advances in therapeutic interventions and increasing clinical awareness. https://hallbook.com.br/blogs/773097/Ornithine-Transcarbamylase-Deficiency-Treatment-Market-Growth-Driven-by-Innovative-Therapies